EU aims to stockpile critical medical supplies for future crises
FILE PHOTO: Hadja Lahbib, European Commissioner for Preparedness, Crisis Management and Equality, attends the London Sudan conference, marking the two-year anniversary of the Sudan conflict, at Lancaster House, in London, Britain April 15, 2025. REUTERS/Isabel Infantes/Pool/File Photo
BRUSSELS - The European Union aims to stockpile critical medical equipment and vaccines in case of future health crises and to set up a network to ease coordination among EU countries, European crisis chief Hadja Lahbib said on Wednesday.
The 27-country bloc is scarred by the memory of the COVID-19 pandemic when it faced a shortage of vaccines and protective masks.
"We need a long-term strategy to make sure that essential supplies that keep society running are always available," European Commissioner Lahbib told a news conference.
Under the EU Stockpiling and Medical Countermeasures Strategies, the EU will draw up a priority list of medical equipment to be stockpiled in Europe, including vaccines, therapeutics, diagnostics, and personal protective equipment.
The EU will double investments in the Health Emergency Preparedness and Response, known as HERA for short, to 200 million euros ($234 million) by 2027, Lahbib said. The scheme funds research and development projects.
She said the European Commission will also launch a Medical Countermeasures Accelerator to serve as a one-stop shop to help companies access financing to develop health technologies.
A European and Global Wastewater Sentinel System will be set up to collect samples from European airports to detect disease hotspots and monitor in real time the evolution of outbreaks.
Top stories
Swipe. Select. Stay informed.
Singapore Singapore to hire more than 1,000 new educators annually in the next few years, up from 700
Singapore COE prices rise for all categories
Asia Malaysia confirms existence of document central to ex-PM Najib's house arrest bid, reports say
Singapore Man who killed cats by throwing them off HDB blocks has jail term doubled to 27 months
Singapore $43k fine for undischarged bankrupt doctor who failed to disclose assets worth over $4m
Singapore Female primary school teacher charged over alleged sex acts with underage male student
Singapore Goodbye fraudsters? Dating app Coffee Meets Bagel rolls out identity verification
Asia Amid handshakes and familiar friends, Asean navigates tariffs and tension in KL
Under a measure called the Medifence initiative, the EU will collaborate with NATO's Joint Health group to draw up a list of dual-use medical countermeasures - usable for both military and civilian purposes - such as antidotes and chemical protections.
As part of the Stockpiling Strategy, the EU will develop a Stockpiling Network with member states to coordinate their initiatives and avoid duplicate funding.
"We know that some countries are stockpiling on their own, but we don't know who has what. The first step is to exchange information," Lahbib said. REUTERS
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
5 hours ago
- Straits Times
Italy's abortion taboos challenged by new law in Sicily
Sign up now: Get ST's newsletters delivered to your inbox FILE PHOTO: People demonstrate outside the Ministry of Health to demand the right to free, safe and free abortion as Non Una di Meno (Not One Less) movement and feminist collectives take part in a protest to mark the International Safe Abortion Day, in Rome, Italy September 28, 2024. REUTERS/Yara Nardi/File Photo CATANIA, Italy - Monia, a Sicilian woman in her early forties, was overjoyed when she discovered in October 2022 she was expecting her first child. Her doctor, however, recommended a genetic test due to her age, and the result was one no parent wants to receive. The foetus had a genetic syndrome. Monia, who declined to give her surname, asked her gynaecologist what she could do. "Nothing. You don't want to terminate, do you?" the doctor asked her, she said. He was a conscientious objector, Monia said, one of hundreds on the southern Italian island. More than 80% of gynaecologists in Sicily refuse to perform abortions for moral or religious reasons, according to the latest health ministry data, which dates to 2022, even though the procedure has been a legal right for women in Italy since 1978. To address that situation, in late May Sicily's regional council - run by a centre-right coalition - passed a law in a secret ballot requiring all public hospitals to create dedicated abortion wards and to hire staff willing to provide the service. Under the national rules, abortion is permitted within the first 90 days of a pregnancy, or later if there are risks to the mother's health or foetal abnormalities. The latter circumstance applied to Monia, who went to the Sant'Antonio Abate hospital in the city of Trapani, in western Sicily, to terminate her pregnancy. "All the gynaecologists were objectors," she said. "An obstetrician gave me a bed with only a mattress cover and said they would administer a pill every three hours until I went into labour." She was told she would receive no further assistance. Top stories Swipe. Select. Stay informed. Singapore Singapore to train more aviation and maritime officials from around the world Business Singapore's economy sees surprise expansion in Q2 despite US tariff uncertainty: Advance estimate Singapore Same person, but different S'porean Chinese names? How have such naming practices evolved? Singapore Jail for woman who opened bank accounts that received over $640m including scam proceeds Business From wellness zone to neurodivergent room: How companies are creating inviting, inclusive offices Singapore Swift action needed to stop vaping's slide from health risk to drug epidemic Singapore Govt will continue to support families, including growing group of seniors: PM Wong at PCF Family Day Singapore Art by Pathlight students to be displayed along Singapore River Her story is far from unique in southern Italy, where cultural traditions are more conservative than in the Catholic country's richer north and centre. At first, Monia's pills were ineffective, but after five days and a change of treatment she finally miscarried, attended to by a doctor and a midwife. Hospital staff referred to her as "Article 6," she said, after the provision in the law that allows abortions beyond 90 days. In response to a request for comment, the Sant'Antonio Abate hospital said it was sorry for Monia's "difficult experience". However, the hospital said it was unable to verify the facts because both the hospital manager and the head of the gynaecology department at that time had left. The hospital said it now has three non-objecting doctors and was able to provide abortion services. Abortions are only available in around half of Sicily's hospitals, health ministry data shows, a figure much lower than in central and northern Italy, where rates are around 70%. Like most of his colleagues, Fabio Guardala, a 60-year-old doctor, refuses to perform abortions. He operates at the Cannizzaro hospital in the Sicilian city of Catania, on the east coast of the island. "A doctor's job is to heal," said Guardala, who is also deputy head of a healthcare unit at his local Catholic church. "Abortion is not treatment but killing. Nobody can force a doctor to kill." Silvia Vaccari, president of the Italian federation of midwives, FNOPO, said health outcomes can be grim in areas where legal abortions are hard to access. "The absence of facilities sometimes leads people to turn to non-professionals, putting them at risk of death, or to continue with pregnancies and give birth to babies who are abandoned in places where they may never be found alive," she said. CATHOLIC INFLUENCE Most other European Union countries allow health workers to refuse to perform abortions on ethical grounds, according to a 2022 study published in the Acta Biomedica journal. But the right is generally exercised far less commonly than in southern Italy. One exception is deeply Catholic Poland, where abortion is only legal in cases of rape or incest or when a woman's health or life is at risk. The Acta study said many Polish women have been forced to travel abroad to terminate their pregnancies. Abortion has always been contentious in Italy, a Catholic country that hosts the Vatican. Right-wing Prime Minister Giorgia Meloni passed legislation last year to try to deter women from terminating pregnancies. Pro-life groups have been allowed into abortion advice clinics, in a move Meloni's party said was aimed at giving women an opportunity for reflection before making a final decision. Nationally, the number of abortions dropped to 65,000 in 2022, according to the latest health ministry data, against 110,000 in 2011. More than 60% of gynaecologists are conscientious objectors. On the island of Sardinia, the region's ruling, left-leaning 5-Star Movement last month presented a law proposal similar to the one adopted in Sicily, suggesting that other southern regions may soon follow its example. Dario Safina, a centre-left Democratic Party lawmaker in Sicily and the promoter of the new law, said many Sicilian women seeking an abortion feel forced to resort to the private sector. "Access to abortion is not a problem for those who can afford it, because they can go to a private clinic. But healthcare based on wealth is the end of democracy," he said. Some doctors argue Sicily's high objection rates are not only due to ethics but also to staff shortages and poor working conditions that make it harder for gynaecologists to provide abortions on top of their regular duties. Data from the GIMBE Foundation, a health sector think-tank, shows Sicily had nine healthcare workers per 1,000 residents in 2022, compared with a national average of 11.6 and far below the northern and central Emilia Romagna and Tuscany regions with 15. "Hospitals always try to exploit doctors' work without paying them properly, so sometimes professionals are reluctant to perform abortions," said Salvatore Incandela, head of the Sicilian arm of AOGOI, Italy's gynaecologists' association. Italian anti-abortion group Pro-Life Together rejects this, saying non-objectors in Sicily were only required to perform 1.5 abortions a week on average in 2022 - still above a national average of 0.9. LEGAL CHALLENGES? Six Sicilian hospital managers and health professionals contacted by Reuters said the new legislation could strengthen the service, but it was still important to ensure doctors could opt out as allowed under 1978 national law that sanctioned the right to abortion. Under the law, health workers are exempted from abortion procedures if they declare an ethical or religious objection, so long as the woman's life is not in immediate danger. Gaetano Sirna, the director general of Catania's Policlinico-San Marco hospital, one of the city's largest, said even with just six non-objecting gynaecologists out of a total of 39, he could still ensure abortions for those who needed them. "We have no problems guaranteeing the availability (of doctors) ... gynaecologists are free to declare themselves as objectors; we do not discriminate," he told Reuters. Abortion is not the only case in which conscientious objection is permitted in Italy. It used to be grounds for avoiding compulsory military service, which was abolished in the early 2000s, and an opt-out for scientists from conducting animal experiments was introduced in the early 1990s. Giorgia Landolfo, a pro-abortion activist in Catania, called the new law in Sicily a "landmark," but said she feared it would be hard to enforce. Some anti-abortion groups say it will be challenged in court on the ground that job postings reserved for non-objectors discriminate against the others. "Many measures in the past aimed at hiring non-objectors have been challenged and ultimately came to nothing," said Vito Trojano, the head of SIGO, the Italian Obstetrics and Gynaecology Society. Some Sicilian politicians who strongly oppose the new rules believe the region should instead bolster its healthcare and support facilities for pregnant women, who often feel abandoned and see no alternative to abortion. "Life is life from the moment of conception," said Margherita La Rocca, a Sicilian lawmaker from the centre-right Forza Italia party. "The foetus cannot just be considered a clump of cells when it's convenient." REUTERS
Straits Times
13 hours ago
- Straits Times
Forum: End of free test kit distribution can hurt fight against cancer here
Sign up now: Get ST's newsletters delivered to your inbox C olorectal cancer remains one of the leading causes of cancer-related deaths among Singaporeans aged 50 and above, particularly when not detected early. For years, the Singapore Cancer Society, with government support, has played a vital role in raising public awareness and encouraging early screening through its outreach campaigns. One of its most impactful efforts was the community distribution of free faecal immunochemical test kits – a simple yet effective tool to detect hidden blood in stools, which can be an early sign of colorectal cancer. As someone who regularly responded to these screening initiatives, I am grateful for this public health effort. It has helped to normalise the conversation around cancer screening and enabled early detection for many Singaporeans, especially those who would otherwise not have sought screening on their own. However, I was surprised and disheartened to learn recently that the Singapore Cancer Society has stopped distributing these kits, which now have to be collected through Healthier SG healthcare providers, where doctor consultation and screening test fees may apply. Given the ageing population in Singapore and the proven effectiveness of early screening, this shift feels like a step backwards in our nation's fight against cancer. Top stories Swipe. Select. Stay informed. Singapore Govt will continue to support families, including growing group of seniors: PM Wong at PCF Family Day Singapore From Normal stream to Parliament: 3 Singapore politicians share their journeys World Deal or no deal? EU faces critical decision in response to Trump's latest tariff salvo Singapore Segregated recycling bins found to lower contamination rate as more spring up Sport Two participants injured after another breached safety protocol during Pesta Sukan archery event Asia Mahathir discharged from hospital after feeling fatigued during birthday gathering Singapore Medics treat 7 after blaze at HDB block lift lobby in Chai Chee Singapore I lost my daughter to Kpod addiction: Father of 19-year-old shares heartbreak and lessons Ho Kheng Tiong
Straits Times
13 hours ago
- Straits Times
Locally developed cancer drug shows promise as treatment for blindness; trial to start soon
Sign up now: Get ST's newsletters delivered to your inbox Professor Qi Zeng (seated) and her team of scientists, including Dr David Ang (standing behind her), have evaluated the drug known as PRL3-zumab for 20 years. SINGAPORE – A locally developed drug for cancer treatment will be used in a trial in Singapore on patients to prevent vision loss. It will be administered intravenously to patients with wet age-related macular degeneration (AMD) or diabetic retinopathy, both currently treated with a shot of medicine injected into the eye. The two conditions are among the most common causes of vision loss globally. In pre-clinical studies published in Nature Communications, the drug known as PRL3-zumab effectively reduced leakage from damaged blood vessels – a major cause of vision loss. This pointed to a possible new treatment option for patients whose eye conditions do not respond well to current therapies. The findings for the drug came from the A*Star Institute of Molecular and Cell Biology (IMCB), which had originally developed it, and its biotech spin-off Intra-ImmuSG. Wet AMD and diabetic retinopathy share a common treatment approach: periodic injections administered directly into the white part of the eye, or sclera, as often as once a month. This is done to reduce abnormal blood vessel growth and leakage. A*Star senior scientist David Ang Koon Hwee said he was driven to explore the intravenous application of PRL3-zumab for the two eye conditions after witnessing his late father struggle for several years with the injections to treat his diabetic eye complication. Moreover, a significant portion of the patients who need these injections do not respond adequately to them. The pre-clinical studies showed that the intravenous delivery of PRL3-zumab led to an 86 per cent greater reduction in abnormal blood vessel leakage, compared with injections into the eye. 'When the blood vessels are broken and start to leak, it is like a water pipe that is leaking... This drug can reduce the leakage,' said Dr Ang, who added that the current standard care treatments cannot be given intravenously because of their toxicity. PRL3-zumab has been tested in 210 advanced cancer patients so far, with a good safety profile, he said. Phase II trials for the drug were conducted in Singapore, the United States, China and, most recently, Malaysia. Professor Qi Zeng, A*Star IMCB senior principal scientist and founder of Intra-ImmuSG, said she and a team of researchers have evaluated the drug for 20 years now – it targets only diseased tissues and not normal, healthy tissues, rendering it very safe. She first identified the PRL3 protein, which is found in many cancers, in 1998. Singapore's Health Sciences Authority granted approval on June 16 for the human trial to test PRL3-zumab as an alternative intravenous treatment to eye injections in treating wet AMD and diabetic retinopathy. The safety trial, which will have 15 patients, is expected to begin by late 2025, following which more human trials will be needed to show that it is effective.
